Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
OR ›
ORELVO
Trademark search for:
ORELVO
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2017-09-12 — Application filed
2017-09-15 — Application filed
2017-09-15 — Application filed
2017-12-15 — Assigned to examiner
2017-12-15 — Suspension letter written
2017-12-15 — Letter of suspension e-mailed
2017-12-15 — Notification of letter of suspension e-mailed
2018-07-11 — Assigned to lie
2018-07-13 — Suspension checked - to attorney for action
2018-08-04 — Suspension inquiry written
2018-08-04 — Inquiry to suspension e-mailed
2018-08-04 — Notification of inquiry as to suspension e-mailed
2019-01-30 — Teas response to suspension inquiry received
2019-01-31 — Correspondence received in law office
2019-01-31 — Teas/email correspondence entered
2019-02-21 — Suspension letter written
2019-02-21 — Letter of suspension e-mailed
2019-02-21 — Notification of letter of suspension e-mailed
2019-08-22 — Suspension checked - to attorney for action
2019-09-09 — Suspension inquiry written
2019-09-09 — Inquiry to suspension e-mailed
2019-09-09 — Notification of inquiry as to suspension e-mailed
2020-02-05 — Teas response to suspension inquiry received
2020-02-10 — Correspondence received in law office
2020-02-10 — Teas/email correspondence entered
2020-03-04 — Suspension letter written
2020-03-04 — Letter of suspension e-mailed
2020-03-04 — Notification of letter of suspension e-mailed
2020-09-09 — Suspension checked - to attorney for action
2020-10-01 — Suspension inquiry written
2020-10-01 — Inquiry to suspension e-mailed
2020-10-01 — Notification of inquiry as to suspension e-mailed
2021-04-19 — Assigned to examiner
2021-04-19 — Application abandoned
2021-04-19 — Final status recorded
2021-04-20 — Application abandoned
Owner Information
Aurinia Pharmaceuticals Inc.
Correspondent
Matthew R. Wilmot STOEL RIVES LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
